E-LIB Suche - Ergebnisse für: Lacour, Jean-Philippe

1

Efficacy and safety of apremilast in patients with moderate..:

Merola, Joseph F. ; Parish, Lawrence Charles ; Guenther, Lyn...
Journal of the American Academy of Dermatology. 90 (2024) 3 - p. 485-493 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy of Apremilast in Patients with Moderate-to-Severe ..:

Merola, Joseph F. ; Parish, Lawrence Charles ; Guenther, Lyn...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s255 , 2023

Link: https://doi.org/10.25251..

3

40665 Efficacy of Apremilast in Patients With Moderate-to-S..:

Merola, Joseph F. ; Parish, Lawrence Charles ; Guenther, Lyn...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB158 , 2023

Link: https://doi.org/10.1016/..

4

A long-term, prospective, observational cohort study of the..:

Gu, Yun ; Brinkley, Emma ; Largent, Joan...
European Journal of Dermatology. 33 (2023) 1 - p. 25-33 , 2023

Link: https://doi.org/10.1684/..

5

Efficacy and Safety of Apremilast in Patients With Genital ..:

Merola, Joseph ; Parish, Lawrence ; Guenther, Lyn...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s110 , 2023

Link: https://doi.org/10.25251..

6

Clinicopathologic and molecular analyses of cutaneous leiom..:

Planet, Camille ; Dalle, Stéphane ; Dereure, Olivier...
Journal of the American Academy of Dermatology. 88 (2023) 1 - p. 215-216 , 2023

Link: https://doi.org/10.1016/..

7

Long-term 2-year safety and efficacy of tralokinumab in adu..:

Blauvelt, Andrew ; Langley, Richard G. ; Lacour, Jean-Philippe...
Journal of the American Academy of Dermatology. 87 (2022) 4 - p. 815-824 , 2022

Link: https://doi.org/10.1016/..

8

33307 Nemolizumab is associated with a rapid reduction of i..:

Ständer, Sonja ; Yosipovitch, Gil ; Lacour, Jean-Philippe...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB185 , 2022

Link: https://doi.org/10.1016/..

9

Efficacy and safety of baricitinib in combination with topi..:

Bieber, Thomas ; Reich, Kristian ; Paul, Carle...
British Journal of Dermatology. 187 (2022) 3 - p. 338-352 , 2022

Link: https://doi.org/10.1111/..

10

33124 Severe infections, confirmed extended major adverse c..:

Pinter, Andreas ; Lacour, Jean-Philippe ; Egeberg, Alexander
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB108 , 2022

Link: https://doi.org/10.1016/..

11

Interleukin-33 antibody failed to demonstrate benefit in a ..:

Laquer, Vivian ; Parra, Viviana ; Lacour, Jean-Philippe...
British Journal of Dermatology. 187 (2022) 4 - p. 599-602 , 2022

Link: https://doi.org/10.1111/..

12

Improvement of patient outcomes following therapeutic optim..:

Giordano-Labadie, Françoise ; Becherel, Pierre-André ; Pralong, Pauline...
European Journal of Dermatology. 31 (2021) 2 - p. 217-224 , 2021

Link: https://doi.org/10.1684/..

13

Twice-weekly topical calcipotriene/betamethasone dipropiona..:

Lebwohl, Mark ; Kircik, Leon ; Lacour, Jean-Philippe...
Journal of the American Academy of Dermatology. 84 (2021) 5 - p. 1269-1277 , 2021

Link: https://doi.org/10.1016/..

14

Long-Term Improvements Observed in Tralokinumab-Treated Pat..:

Blauvelt, Andrew ; Lacour, Jean-Philippe ; Toth, Darryl...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 6 - p. s59 , 2021

Link: https://doi.org/10.25251..

15

Targeting immunoglobulin E in atopic dermatitis: A review o..:

Wollenberg, Andreas ; Thomsen, Simon Francis ; Lacour, Jean-Philippe..
World Allergy Organization Journal. 14 (2021) 3 - p. 100519 , 2021

Link: https://doi.org/10.1016/..